Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

NCT05041309 · clinicaltrials.gov ↗

ENROLLING_BY_INVITATION

Status

1000

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid and Hematological Malignancies

Interventions

BIOLOGICAL: Axicabtagene Ciloleucel
BIOLOGICAL: Brexucabtagene Autoleucel
BIOLOGICAL: Anitocabtagene autleucel
BIOLOGICAL: KITE-753
BIOLOGICAL: KITE-197
BIOLOGICAL: KITE-363

Sponsor

Kite, A Gilead Company